TCL Archive Seer Places Survival Now at Least At 45 Percent, Could Be As High As 50 Percent For 1973-79 Patients December 4, 1981
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive In Brief: Levin Leaves UCSF for M.D. Anderson; Copeland Moves to Ohio State; OC’s Alice Hamm Retires July 1, 1988
